CDSCO Current Affairs - 2020

Category Wise PDF Compilations available at This Link

First “Made in India” COVID-19 Test Kit gets commercial approval from CDSCO

A Pune based testing services MyLab has become the first Indian company to get an commercial approval from CDSCO for the sales of COVID-19 testing kits sale.

About the Kit

The kit was developed by MyLab testing services. The testing time of COVID-19 in current lab testing services is 4 hours. However, MyLAb’s testing time is 2 ½ hours. The laboratory is to sell the kits at Rs 1,200 to Rs 1,500 per test. Currently, the Government of India has fixed the cap price of COVID-19 as Rs 4,500. No laboratory in India can charge more than this fixed amount to test the COVID-19. The move was made after the Indian Government allowed the private organizations to test for the virus.

A single kit can study 1000 samples. The testing methodology adopted have been validated by National Institute of Virology. The kits are based on Reverse Transcription Polymerase Chain reaction

Significance

Currently, India ranks lowest in testing of COVID-19 virus. Currently India is testing only 15 people in 1 million.

Get these updates on Current Affairs Today Android App

President Trump visit to India: 2 MoUs and 1 Letter of Cooperation signed

On February 24, 2020, the US President Donald Trump visited India along with his wife Melania Trump. On the sidelines of his visit, agreements were signed in the field of health, oil and defence.

Highlights

In the Defence Sector, 3 billion USD worth deal was signed to buy helicopters. The Memorandum of Understandings were signed in the field of oil and health. In the field of health, Central Drugs Standard Control Organization and the US Food and Drug Administration signed agreements over the safety of medical products.

Significance of MoU with USFDA

It is essential to be on good equations with the USFDA and also abide by its regulations. This is because, the pharmaceutical exports to USA require USFDA certification. And US is the top export destination of Pharmaceuticals for India. In 2018-19, around 5820 million USD worth pharmaceuticals were exported to US from India.

The signing of this MoU will help the pharmaceuticals increase their exports to US.

Other Agreements

An MoU was also signed between the mental health departments of the countries. The countries also signed a letter of cooperation in the field of Oil.

Get these updates on Current Affairs Today Android App